Plasma and muscle myostatin in relation to type 2 diabetes

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Brandt, Claus ^a   Nielsen, Anders R ^a   Fischer, Christian P ^a   Hansen, Jakob ^a   Pedersen, Bente K ^a   Plomgaard, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 6; MESSENGER RNA; MYOSTATIN; MSTN PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; VASTUS LATERALIS MUSCLE; VENOUS OXYGEN TENSION; BLOOD; GENETICS; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MUSCLE; PHYSIOLOGY;

ANIMALIA;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLES; MYOSTATIN; RNA, MESSENGER;

EID: 84861217337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037236     Document Type: Article

References (31)

1. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, Sinha-Hikim I, Ma K, et al. (1998) Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 95: 14938-14943.
2. McPherron AC, Lawler AM, Lee SJ, (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90.
3. Rodgers BD, Garikipati DK, (2008) Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev 29: 513-534.
4. Zhao B, Wall RJ, Yang J, (2005) Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun 337: 248-255.
5. Wilkes JJ, Lloyd DJ, Gekakis N, (2009) Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 58: 1133-1143.
6. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, et al. (2009) Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS ONE 4: e4937.
7. Sainz N, Rodriguez A, Catalan V, Becerril S, Ramirez B, et al. (2009) Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS ONE 4: e6808.
8. Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, et al. (2008) Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294: E918-E927.
9. Antony N, Bass JJ, McMahon CD, Mitchell MD, (2007) Myostatin regulates glucose uptake in BeWo cells. Am J Physiol Endocrinol Metab 293: E1296-E1302.
10. Mitchell MD, Osepchook CC, Leung KC, McMahon CD, Bass JJ, (2006) Myostatin is a human placental product that regulates glucose uptake. J Clin Endocrinol Metab 91: 1434-1437.
11. Zhang C, McFarlane C, Lokireddy S, Bonala S, Ge X, et al. (2011) Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia 54: 1491-1501.
12. Chen Y, Ye J, Cao L, Zhang Y, Xia W, et al. (2010) Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. Int J Biochem Cell Biol 42: 2072-2081.
13. Palsgaard J, Brons C, Friedrichsen M, Dominguez H, Jensen M, et al. (2009) Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS ONE 4: e6575.
14. Morley JE, Thomas DR, Wilson MM, (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83: 735-743.
15. Mastrocola R, Reffo P, Penna F, Tomasinelli CE, Boccuzzi G, et al. (2008) Muscle wasting in diabetic and in tumor-bearing rats: role of oxidative stress. Free Radic Biol Med 44: 584-593.
16. Nielsen AR, Hojman P, Erikstrup C, Fischer CP, Plomgaard P, et al. (2008) Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab 93: 4486-4493.
17. Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, et al. (2007) Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 50: 2562-2571.
18. STRAND PO, RYHMING I, (1954) A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol 7: 218-221.
19. Levy JC, Matthews DR, Hermans MP, (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21: 2191-2192.
20. Lakshman KM, Bhasin S, Corcoran C, Collins-Racie LA, Tchistiakova L, et al. (2009) Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration. Mol Cell Endocrinol 302: 26-32.
21. Bernardo BL, Wachtmann TS, Cosgrove PG, Kuhn M, Opsahl AC, et al. (2010) Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice. PLoS ONE 5: e11307.
22. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, et al. (2005) Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54: 2939-2945.
23. Fischer CP, Plomgaard P, Hansen AK, Pilegaard H, Saltin B, et al. (2004) Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab 287: E1189-E1194.
24. Fischer CP, (2006) Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 12: 6-33.
25. Louis E, Raue U, Yang Y, Jemiolo B, Trappe S, (2007) Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol 103: 1744-1751.
26. Roth SM, Martel GF, Ferrell RE, Metter EJ, Hurley BF, et al. (2003) Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp Biol Med (Maywood) 228: 706-709.
27. Kim JS, Cross JM, Bamman MM, (2005) Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab 288: E1110-E1119.
28. Coffey VG, Shield A, Canny BJ, Carey KA, Cameron-Smith D, et al. (2006) Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes. Am J Physiol Endocrinol Metab 290: E849-E855.
29. Walker KS, Kambadur R, Sharma M, Smith HK, (2004) Resistance training alters plasma myostatin but not IGF-1 in healthy men. Med Sci Sports Exerc 36: 787-793.
30. Feldman BJ, Streeper RS, Farese RV Jr, Yamamoto KR, (2006) Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A 103: 15675-15680.
31. Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA, (2009) Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58: 30-38.